Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 - Tabular View

Tracking Information

First Received Date ^ICMJE

September 20, 1999

Last Updated Date

December 22, 2008

Start Date ^ICMJE

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Side effects
Cocaine effects

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00000276 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Dopamine Reuptake Inhibitors of Cocaine Abuse - 1

Official Title ^ICMJE

Dopamine Reuptake Inhibitors of Cocaine Abuse

Brief Summary

The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.

Detailed Description

Study Phase

Phase I

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment

Condition ^ICMJE

Cocaine-Related Disorders

Intervention ^ICMJE

Drug: Bupropion

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Terminated

Enrollment ^ICMJE

Completion Date

Primary Completion Date

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Exclusion Criteria:

Gender

Both

Ages

18 Years to 45 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00000276

Responsible Party

Thomas R Kosten, M.D., Yale University School of Medicine / VA Connecticut Healthcare System

Study ID Numbers ^ICMJE

NIDA-09250-1, P50-09250-1

Study Sponsor ^ICMJE

National Institute on Drug Abuse (NIDA)

Collaborators ^ICMJE

VA Connecticut Healthcare System

Investigators ^ICMJE

Principal Investigator:

Thomas R Kosten, M.D.

VA Connecticut Healthcare System

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

December 2008

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP